Toll Free: 1-888-928-9744

Found 11480 Research Reports In Pharmaceuticals & Healthcare
United States Pneumococcal Vaccines Market Report 2021
US$ 3800.00

Notes: Sales, means the sales volume of Pneumococcal Vaccines Revenue, means the sales value of Pneumococcal Vaccines This report studies sales (consumption) of Pneumococcal Vaccines in USA market...

Read More..
August 15, 2016 105 pages
United States MMRV Vaccines Market Report 2021
US$ 3800.00

Notes: Sales, means the sales volume of MMRV Vaccines Revenue, means the sales value of MMRV Vaccines This report studies sales (consumption) of MMRV Vaccines in USA market...

Read More..
August 15, 2016 103 pages
United States Meningococcal Vaccines Market Report 2021
US$ 3800.00

Notes: Sales, means the sales volume of Meningococcal Vaccines Revenue, means the sales value of Meningococcal Vaccines This report studies sales (consumption) of Meningococcal Vaccines in USA market...

Read More..
August 15, 2016 106 pages
United States Hepatitis Vaccines Market Report 2021
US$ 3800.00

Notes: Sales, means the sales volume of Hepatitis Vaccines Revenue, means the sales value of Hepatitis Vaccines This report studies sales (consumption) of Hepatitis Vaccines in USA market...

Read More..
August 15, 2016 104 pages
United States DTP Vaccines Market Report 2021
US$ 3800.00

Notes: Sales, means the sales volume of DTP Vaccines Revenue, means the sales value of DTP Vaccines This report studies sales (consumption) of DTP Vaccines in USA market...

Read More..
August 15, 2016 107 pages
Diabetes & Obesity Drug Development Pipeline Review, 2016
US$ 3995.00

The diabetes and obesity disease cluster is currently dominated by therapeutics indicated for type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM), and the majority of the pipeline, in terms of both quantity and quality of products, is attributable to these indications....

Read More..
December 1, 2016 560 pages
Ophthalmology Drug Development Pipeline Review, 2016
US$ 3995.00

Ophthalmology disorders are associated with the eyes and visual system. If left untreated, serious long-term co-morbidities such as diabetes, and particularly blindness, can arise....

Read More..
December 1, 2016 633 pages
Global Cancer Vaccines Market to 2022 - Robust Growth Driven by Increasing Prevalence, New Therapeutic Vaccine Approvals and Strong Uptake of Treatments Targeting CD19
US$ 4995.00

Global Cancer Vaccines Market to 2022 - Robust Growth Driven by Increasing Prevalence, New Therapeutic Vaccine Approvals and Strong Uptake of Treatments Targeting CD19...

Read More..
November 1, 2016 183 pages
Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation
US$ 6995.00

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation...

Read More..
November 1, 2016 61 pages
Hemophilia A and B Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Increasing Treatment-Receiving Pool, Launch of Long-Acting Replacement Therapies and Non-factor Therapy
US$ 4995.00

Hemophilia A and B Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Increasing Treatment-Receiving Pool, Launch of Long-Acting Replacement Therapies and Non-factor Therapy...

Read More..
November 1, 2016 126 pages
United States Adult Vaccines Market Report 2021
US$ 3800.00

Notes: Sales, means the sales volume of Adult Vaccines Revenue, means the sales value of Adult Vaccines This report studies sales (consumption) of Adult Vaccines in USA market...

Read More..
August 15, 2016 104 pages
Global Synthetic Peptide Vaccine Market Research Report 2021
US$ 2900.00

Notes: Sales, means the sales volume of Synthetic Peptide Vaccine Revenue, means the sales value of Synthetic Peptide Vaccine This report studies Synthetic Peptide Vaccine in Global market...

Read More..
August 15, 2016 106 pages
Spinal Muscular Atrophy (SMA) - Pipeline Review, H2 2016
US$ 2000.00

Global Markets Direct’s, ‘Spinal Muscular Atrophy (SMA) - Pipeline Review, H2 2016’, provides an overview of the Spinal Muscular Atrophy (SMA) pipeline landscape. ...

Read More..
August 10, 2016 116 pages
Cytotoxic T Lymphocyte Protein 4 (Cytotoxic T Lymphocyte Associated Antigen 4 or CD152 or CTLA4) - Pipeline Review, H2 2016
US$ 3500.00

Cytotoxic T Lymphocyte Protein 4 (Cytotoxic T Lymphocyte Associated Antigen 4 or CD152 or CTLA4) - Pipeline Review, H2 2016 Global Markets Direct's, 'Cytotoxic T Lymphocyte Protein 4 (Cytotoxic T Lymphocyte Associated Antigen 4 or CD152 or CTLA4) - Pipeline Review, H2 2016', provides in depth analysis on Cytotoxic T Lymphocyte Protein 4 (Cytotoxic T Lymphocyte Associated Antigen 4 or CD152 or ...

Read More..
October 19, 2016 112 pages
Leishmaniasis (Kala-Azar) - Pipeline Review, H2 2016
US$ 2000.00

Leishmaniasis (Kala-Azar) - Pipeline Review, H2 2016 Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Leishmaniasis (Kala-Azar) - Pipeline Review, H2 2016, provides an overview of the Leishmaniasis (Kala-Azar) (Infectious Disease) pipeline landscape....

Read More..
November 16, 2016 102 pages
Benign Prostatic Hyperplasia - Pipeline Review, H2 2016
US$ 2000.00

Benign Prostatic Hyperplasia - Pipeline Review, H2 2016 Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Benign Prostatic Hyperplasia - Pipeline Review, H2 2016, provides an overview of the Benign Prostatic Hyperplasia (Male Health) pipeline landscape....

Read More..
November 16, 2016 128 pages
Psoriatic Arthritis - Pipeline Review, H2 2016
US$ 2000.00

Psoriatic Arthritis - Pipeline Review, H2 2016 Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Psoriatic Arthritis - Pipeline Review, H2 2016, provides an overview of the Psoriatic Arthritis (Musculoskeletal Disorders) pipeline landscape....

Read More..
November 16, 2016 231 pages
Salivary Gland Cancer - Pipeline Review, H2 2016
US$ 2000.00

Salivary Gland Cancer - Pipeline Review, H2 2016 Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Salivary Gland Cancer - Pipeline Review, H2 2016, provides an overview of the Salivary Gland Cancer (Oncology) pipeline landscape....

Read More..
November 16, 2016 104 pages
Renal Cell Carcinoma - Pipeline Review, H2 2016
US$ 2000.00

Renal Cell Carcinoma - Pipeline Review, H2 2016 Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Renal Cell Carcinoma - Pipeline Review, H2 2016, provides an overview of the Renal Cell Carcinoma (Oncology) pipeline landscape....

Read More..
November 16, 2016 793 pages
Vaginal Atrophy (Atrophic Vaginitis) - Pipeline Review, H2 2016
US$ 2000.00

Vaginal Atrophy (Atrophic Vaginitis) - Pipeline Review, H2 2016 Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Vaginal Atrophy (Atrophic Vaginitis) - Pipeline Review, H2 2016, provides an overview of the Vaginal Atrophy (Atrophic Vaginitis) (Women's Health) pipeline landscape....

Read More..
November 16, 2016 52 pages
Radiodermatitis - Pipeline Review, H2 2016
US$ 2000.00

Radiodermatitis - Pipeline Review, H2 2016 Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Radiodermatitis - Pipeline Review, H2 2016, provides an overview of the Radiodermatitis (Dermatology) pipeline landscape....

Read More..
November 16, 2016 41 pages
Hypoparathyroidism - Pipeline Review, H2 2016
US$ 2000.00

Hypoparathyroidism - Pipeline Review, H2 2016 Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hypoparathyroidism - Pipeline Review, H2 2016, provides an overview of the Hypoparathyroidism (Hormonal Disorders) pipeline landscape....

Read More..
November 16, 2016 51 pages
Tuberculosis - Pipeline Review, H2 2016
US$ 2000.00

Tuberculosis - Pipeline Review, H2 2016 Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Tuberculosis - Pipeline Review, H2 2016, provides an overview of the Tuberculosis (Infectious Disease) pipeline landscape....

Read More..
November 16, 2016 393 pages
Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H2 2016
US$ 2000.00

Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H2 2016 Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H2 2016, provides an overview of the Type 1 Diabetes (Juvenile Diabetes) (Metabolic Disorders) pipeline landscape....

Read More..
November 16, 2016 621 pages
Cellectis S.A. - Product Pipeline Review - 2016
US$ 1500.00

Global Markets Direct's, 'Toray Industries, Inc. - Product Pipeline Review - 2016', provides an overview of the Toray Industries, Inc.'s pharmaceutical research and development focus. ...

Read More..
October 19, 2016 25 pages
Critical Outcome Technologies Inc. - Product Pipeline Review - 2016
US$ 1500.00

Global Markets Direct's, 'Critical Outcome Technologies Inc. - Product Pipeline Review - 2016', provides an overview of the Critical Outcome Technologies Inc.'s pharmaceutical research and development focus. ...

Read More..
October 19, 2016 43 pages
Toray Industries, Inc. - Product Pipeline Review - 2016
US$ 1500.00

Global Markets Direct's, 'Toray Industries, Inc. - Product Pipeline Review - 2016', provides an overview of the Toray Industries, Inc.'s pharmaceutical research and development focus. ...

Read More..
October 19, 2016 43 pages
Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) - Pipeline Review, H2 2016
US$ 3500.00

Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) - Pipeline Review, H2 2016 Global Markets Direct's, 'Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) - Pipeline Review, H2 2016', provides in depth analysis on Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) targeted pipeline therapeutics....

Read More..
October 19, 2016 46 pages
Tumor Necrosis Factor Receptor Superfamily Member 5 (B Cell Surface Antigen CD40 or Bp50 or CDw40 or CD40L Receptor or TNFRSF5 or CD40) - Pipeline Review, H2 2016
US$ 3500.00

Tumor Necrosis Factor Receptor Superfamily Member 5 (B Cell Surface Antigen CD40 or Bp50 or CDw40 or CD40L Receptor or TNFRSF5 or CD40) - Pipeline Review, H2 2016 Global Markets Direct's, 'Tumor Necrosis Factor Receptor Superfamily Member 5 (B Cell Surface Antigen CD40 or Bp50 or CDw40 or CD40L Receptor or TNFRSF5 or CD40) - Pipeline Review, H2 2016', provides in depth analysis on Tumor Necros...

Read More..
October 19, 2016 70 pages
Tumor Necrosis Factor Receptor Superfamily Member 4 (ACT35 Antigen or TAX Transcriptionally Activated Glycoprotein 1 Receptor or OX40L Receptor or CD134 or TNFRSF4) - Pipeline Review, H2 2016
US$ 3500.00

Tumor Necrosis Factor Receptor Superfamily Member 4 (ACT35 Antigen or TAX Transcriptionally Activated Glycoprotein 1 Receptor or OX40L Receptor or CD134 or TNFRSF4) - Pipeline Review, H2 2016 Global Markets Direct's, 'Tumor Necrosis Factor Receptor Superfamily Member 4 (ACT35 Antigen or TAX Transcriptionally Activated Glycoprotein 1 Receptor or OX40L Receptor or CD134 or TNFRSF4) - Pipeline Re...

Read More..
October 19, 2016 55 pages
Aurora Kinase C (Aurora 3 or Aurora/IPL1 Related Kinase 3 or Aurora/IPL1/Eg2 Protein 2 or Serine/Threonine Protein Kinase 13 or Serine/Threonine Protein Kinase Aurora C or AURKC or EC 2.7.11.1) - Pipeline Review, H2 2016
US$ 3500.00

Aurora Kinase C (Aurora 3 or Aurora/IPL1 Related Kinase 3 or Aurora/IPL1/Eg2 Protein 2 or Serine/Threonine Protein Kinase 13 or Serine/Threonine Protein Kinase Aurora C or AURKC or EC 2....

Read More..
October 19, 2016 39 pages
Protein Kinase C Epsilon Type (nPKC Epsilon or PRKCE or EC 2.7.11.13) - Pipeline Review, H2 2016
US$ 3500.00

Protein Kinase C Epsilon Type (nPKC Epsilon or PRKCE or EC 2....

Read More..
October 19, 2016 47 pages
Complement C5 (C3 And PZP Like Alpha 2 Macroglobulin Domain Containing Protein 4 or C5) - Pipeline Review, H2 2016
US$ 3500.00

Complement C5 (C3 And PZP Like Alpha 2 Macroglobulin Domain Containing Protein 4 or C5) - Pipeline Review, H2 2016 Global Markets Direct's, 'Complement C5 (C3 And PZP Like Alpha 2 Macroglobulin Domain Containing Protein 4 or C5) - Pipeline Review, H2 2016', provides in depth analysis on Complement C5 (C3 And PZP Like Alpha 2 Macroglobulin Domain Containing Protein 4 or C5) targeted pipeline t...

Read More..
October 19, 2016 110 pages
Metabotropic Glutamate Receptor 2 (GPRC1B or MGLUR2 or GRM2) - Pipeline Review, H2 2016
US$ 3500.00

Metabotropic Glutamate Receptor 2 (GPRC1B or MGLUR2 or GRM2) - Pipeline Review, H2 2016 Global Markets Direct's, 'Metabotropic Glutamate Receptor 2 (GPRC1B or MGLUR2 or GRM2) - Pipeline Review, H2 2016', provides in depth analysis on Metabotropic Glutamate Receptor 2 (GPRC1B or MGLUR2 or GRM2) targeted pipeline therapeutics....

Read More..
October 19, 2016 59 pages
Corticosteroid 11 Beta Dehydrogenase Isozyme 1 (11 Beta Hydroxysteroid Dehydrogenase 1 or Short Chain Dehydrogenase/Reductase Family 26C Member 1 or HSD11B1 or EC 1.1.1.146) - Pipeline Review, H2 2016
US$ 3500.00

Corticosteroid 11 Beta Dehydrogenase Isozyme 1 (11 Beta Hydroxysteroid Dehydrogenase 1 or Short Chain Dehydrogenase/Reductase Family 26C Member 1 or HSD11B1 or EC 1....

Read More..
October 19, 2016 71 pages
Apolipoprotein E (APOE) - Pipeline Review, H2 2016
US$ 3500.00

Apolipoprotein E (APOE) - Pipeline Review, H2 2016 Global Markets Direct's, 'Apolipoprotein E (ApoE) - Pipeline Review, H2 2016', provides in depth analysis on Apolipoprotein E (ApoE) targeted pipeline therapeutics....

Read More..
October 19, 2016 39 pages
20s Proteasome - Pipeline Review, H2 2016
US$ 3500.00

20s Proteasome - Pipeline Review, H2 2016 Global Markets Direct's, '20s Proteasome - Pipeline Review, H2 2016', provides in depth analysis on 20s Proteasome targeted pipeline therapeutics....

Read More..
October 19, 2016 69 pages
Apolipoprotein A I (APOA1) - Pipeline Review, H2 2016
US$ 3500.00

Apolipoprotein A I (APOA1) - Pipeline Review, H2 2016 Global Markets Direct's, 'Apolipoprotein A I (APOA1) - Pipeline Review, H2 2016', provides in depth analysis on Apolipoprotein A I (APOA1) targeted pipeline therapeutics....

Read More..
October 19, 2016 57 pages
Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) - Pipeline Review, H2 2016
US$ 3500.00

Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) - Pipeline Review, H2 2016 Global Markets Direct's, 'Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) - Pipeline Review, H2 2016', provides in depth analysis on Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) targeted pipeline therapeutics....

Read More..
October 19, 2016 77 pages
Collagenase 3 (Matrix Metalloproteinase 13 or MMP13 or EC 3.4.24.) - Pipeline Review, H2 2016
US$ 3500.00

Collagenase 3 (Matrix Metalloproteinase 13 or MMP13 or EC 3....

Read More..
October 19, 2016 41 pages
Type 2 Diabetes - Pipeline Review, H2 2016
US$ 2500.00

Type 2 Diabetes - Pipeline Review, H2 2016 Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Type 2 Diabetes - Pipeline Review, H2 2016, provides an overview of the Type 2 Diabetes (Metabolic Disorders) pipeline landscape....

Read More..
November 9, 2016 1298 pages
Obesity - Pipeline Review, H2 2016
US$ 2500.00

Obesity - Pipeline Review, H2 2016 Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Obesity - Pipeline Review, H2 2016, provides an overview of the Obesity (Metabolic Disorders) pipeline landscape....

Read More..
November 9, 2016 537 pages
Bladder Cancer - Pipeline Review, H2 2016
US$ 2000.00

Bladder Cancer - Pipeline Review, H2 2016 Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Bladder Cancer - Pipeline Review, H2 2016, provides an overview of the Bladder Cancer (Oncology) pipeline landscape....

Read More..
November 9, 2016 742 pages
Hepatitis A - Pipeline Review, H2 2016
US$ 2000.00

Hepatitis A - Pipeline Review, H2 2016 Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hepatitis A - Pipeline Review, H2 2016, provides an overview of the Hepatitis A (Infectious Disease) pipeline landscape....

Read More..
October 30, 2016 34 pages
Retinoblastoma - Pipeline Review, H2 2016
US$ 2000.00

Retinoblastoma - Pipeline Review, H2 2016 Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Retinoblastoma - Pipeline Review, H2 2016, provides an overview of the Retinoblastoma (Oncology) pipeline landscape....

Read More..
October 30, 2016 60 pages
Cataract - Pipeline Review, H2 2016
US$ 2000.00

Cataract - Pipeline Review, H2 2016 Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cataract - Pipeline Review, H2 2016, provides an overview of the Cataract (Ophthalmology) pipeline landscape....

Read More..
October 30, 2016 43 pages
Posterior Uveitis - Pipeline Review, H2 2016
US$ 2000.00

Posterior Uveitis - Pipeline Review, H2 2016 Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Posterior Uveitis - Pipeline Review, H2 2016, provides an overview of the Posterior Uveitis (Ophthalmology) pipeline landscape....

Read More..
October 30, 2016 65 pages
Thymic Carcinoma - Pipeline Review, H2 2016
US$ 2000.00

Thymic Carcinoma - Pipeline Review, H2 2016 Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Thymic Carcinoma - Pipeline Review, H2 2016, provides an overview of the Thymic Carcinoma (Oncology) pipeline landscape....

Read More..
November 9, 2016 87 pages
Oropharyngeal Cancer - Pipeline Review, H2 2016
US$ 2000.00

Oropharyngeal Cancer - Pipeline Review, H2 2016 Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Oropharyngeal Cancer - Pipeline Review, H2 2016, provides an overview of the Oropharyngeal Cancer (Oncology) pipeline landscape....

Read More..
October 30, 2016 144 pages
Atherosclerosis - Pipeline Review, H2 2016
US$ 2000.00

Atherosclerosis - Pipeline Review, H2 2016 Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Atherosclerosis - Pipeline Review, H2 2016, provides an overview of the Atherosclerosis (Cardiovascular) pipeline landscape....

Read More..
November 9, 2016 252 pages
Schedule Free Analyst Call

To schedule a free analyst call, please complete the form below.

Your personal details are safe & secure. Privacy policy

Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify